Prelude Therapeutics Incorporated
USD3.50
-0.32 (-8.38%)
CEO
Krishna Vaddi
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.76
Prev. Close
$3.82
Day Low
$3.47
Day High
$3.76
52W Low
$0.75
52W High
$5.54
Market Cap
$0.20B
Volume
0.37M
| 1,407,000 |
| $0.00 |
| 28 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | J-Other | Acquired | 1,407,000 | $0.00 |
| 28 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Disposed | 0 | $0.00 |
| 23 Apr 2026 | Bonita David P | director, 10 percent owner: | P-Purchase | Acquired | 1,689,189 | $4.44 |
| 23 Apr 2026 | Bonita David P | director, 10 percent owner: | P-Purchase | Acquired | 1,126,126 | $4.44 |
| 23 Apr 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | Acquired | 1,689,189 | $4.44 |
| 23 Apr 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | Acquired | 1,126,126 | $4.44 |
| 22 Apr 2026 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | P-Purchase | Acquired | 114,601 | $0.00 |
| 22 Apr 2026 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | P-Purchase | Acquired | 2,137,651 | $0.00 |